The global Automated Patch Clamp System Market is estimated to be valued at US$ 503.32 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Automated patch clamp systems are instruments used to record currents in cell membranes through tiny pores or “patches.” They offer higher throughput and reproducibility compared to manual patch clamping. The systems enable ion channel characterization in drug discovery and safety pharmacology studies. Market key trends: Growing demand for ion channel screening in drug discovery presents key growth opportunities for automated patch clamp systems. Ion channels play an important role in cellular functions and many diseases. Drug screening requires profiling of candidate compounds against a wide range of ion channels. Automated systems facilitate high-throughput screening against various ion channel targets. Furthermore, they provide reproducibility and enable validation of manually obtained results through parallel recordings. This fuels their increasing adoption over conventional manual patch clamping in ion channel research and drug development. Segment Analysis Automated patch clamp systems market is segmented into the type of assays, throughput, end-user, and region. Based on the type of assays, the automated patch clamp systems market is segmented into voltage clamp, current clamp, and combined (hybrid) clamp. The voltage clamp segment dominated the market in 2019 due to its high usage for evaluating ion channel function. Voltage clamp allows the study of voltage-dependent ion channel function and cellular excitability by clamping the voltage across the cell membrane and recording ionic currents. Key Takeaways The Global Automated Patch Clamp System Market Demand is expected to witness high growth, exhibiting a CAGR of 11% over the forecast period, due to increasing demand and application of patch clamp techniques in drug discovery and development. Regional analysis – North America accounted for the largest share of the automated patch clamp systems market in 2019 due to strong research funding and presence of key players in the region. Asia Pacific is expected to grow at the highest CAGR during the forecast period due to increasing R&D investments and heavy funding for drug discovery in countries such as China and India. Key players operating in the Automated Patch Clamp System market are Sophion Bioscience A/S, Nanion Technologies GmbH, NeoBiosystems, Inc., Multi Channel Systems MCS GmbH, Fluxion Biosciences, Molecular Devices, LLC, Scitech Korea Inc., and HEKA Elektronik GmbH. Sophion Bioscience A/S dominated the market in 2019 owing to its robust product portfolio and strong global presence. Molecular Devices, LLC also holds a significant share due to its expanded product range. Note: 1. Source: Coherent Market Insights, Public sources, Desk research 2. We have leveraged AI tools to mine information and compile it

by Kiran ChauhanNovember 14, 2023